Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Breast Neoplasms 1

Interventions

Cyclophosphamide 240Radiotherapy 216Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Rituximab 141Capecitabine 141pembrolizumab 139Oxaliplatin 124Nivolumab 124Dexamethasone 122Fluorouracil 113fludarabine 103Radiosurgery 101Doxorubicin 99fludarabine phosphate 96Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 91Magnetic Resonance Spectroscopy 90Radiation 89Leucovorin 88Filgrastim 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER × Multimodal Imaging × Clear all
NCT03285841 2024-03-18

OCT-AF Imaging of Pre-cancers of Vulva and Cervix

British Columbia Cancer Agency

Terminated
20 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Vulvar Neoplasms

NCT00804544 2012-03-05

99mTc-MIBI SPECT/CT in Breast Malignancy

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Terminated
4 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡